Cogentus Pharmaceuticals, Inc. (extinct)

Cogentus Pharmaceuticals, Inc. (extinct)

Cogentus Pharmaceuticals, Inc. (extinct)

Date Founded



301 Ravenswood Avenue,Suite 100,Menlo Park, CA 94025-3434

Type of Company




Company Description

Cogentus Pharmaceuticals, Inc. develops pharmaceutical products. Its investors include The Keffi Group, Prospect Venture Partners, Ridgeback Capital, Apothecary Capital, and Pinnacle Ventures. The company was founded by Mark A. Goldsmith in 2006 and is headquartered in Menlo Park, CA

Paths to Cogentus Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
Cogentus Pharmaceuticals, Inc.
Details Hidden

Prospect Venture Partners focuses on investments in commercially attractive biomedical technology and life science companies that have management teams, proprietary products and innovative technology or services. They participate in new company incubations,seed, first and second venture financing rounds and expansion capital financings of later-stage private and public companies with proven business models. Initial investments range from $500,000 to $10 million with $10 million to $20 million invested over the life of a company. Prospect Venture Partners will serve as a lead investor or as a co-lead in a syndicate. The firm typically takes a seat on the boards of their portfolio companies.

Details Hidden

Pinnacle Ventures is an active manager, which invests in companies located in the US. The firm follows of information technology, commercial & health services and health technology. It provides financing for growth capital requirements.

Details Hidden

Ridgeback Capital Management focuses in investments in healthcare companies.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cogentus Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cogentus Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Cogentus Pharmaceuticals, Inc..